Open Access Cell Biology Research
Welcome to Taylor & Francis Open Access Cell Biology Research
We've created this page to provide authors and researchers with quick access to high-quality, fully open content. Open access makes published academic research freely and permanently available online: Anyone, anywhere can read and build upon this research.
Taylor & Francis hopes that by equipping researchers with relevant materials, breakthroughs in understanding cell biology can occur at a quicker pace, yielding better treatment methods with advanced applications in other aspects of medicine.
Click on the links below to explore our range of open access journals in Cell Biology and the different specialties that collectively comprise this portfolio.
Journal of Extracellular Vesicles
An open access journal | 2018 Impact Factor 11.000
Journal of Extracellular Vesicles is the official journal of the International Society for Extracellular Vesicles. It provides a much-needed forum for the exchange of data, ideas and information from all areas pertaining to the chemistry, biology and/or applications of extracellular vesicles, including microvesicles, exosomes, ectosomes, apoptotic bodies and other extracellular vesicles.
JEV welcomes original research papers, review articles, short communications, technical reports, position papers, editorials, and letters to the editor. Supplementary material in the form of large datasets, protocols, videos etc. are encouraged. Thematic clusters of articles (special issues) and supplements are published occasionally and are collated into online collections. Abstracts from the society’s annual meetings are also published within the journal.
An open access journal | 2018 Impact Factor 4.405
A multi-disciplinary journal dedicated to the art and science of antibody research and development. mAbs has a strong scientific and medical focus, which strives to serve a broader readership of scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.
The articles are of interest to scientists, clinical researchers and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics. mAbs publishes relevant and timely original research, as well as authoritative overviews, commentary and perspectives providing context for the work presented in mAbs and for key results published elsewhere.
Journal of Enzyme Inhibition and Medicinal Chemistry
An open access journal | 2018 Impact Factor 4.027
Publishing new knowledge and findings on enzyme inhibitors and inhibitory processes and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents and an understanding of their action.
Among various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.
Dove Medical Press
Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa Plc
Dove Press specializes in the publication of open access, peer-reviewed journals across the spectrum of science, technology and medicine. Our journals are indexed online via PubMed and PubMed Central, as well as in other notable indexing services. We publish several journals that address Cell Biology—explore for yourself and discover high-quality, fully open research.